Status:
NOT_YET_RECRUITING
Robotic vs Open Pancreatoduodenectomy
Lead Sponsor:
Hospital del Mar
Conditions:
Pancreas Neoplasms
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Pancreatic surgery, specifically pancreatoduodenectomy (PD), is a complex procedure often required for patients with pancreatic or other periampullary cancers. In recent years, minimally invasive tech...
Detailed Description
Introduction Pancreatoduodenectomy (PD), commonly known as the Whipple procedure, is a complex surgical procedure used to treat pancreatic, bile duct, and duodenal diseases, including cancer. Traditi...
Eligibility Criteria
Inclusion
- Age 18 years or older.
- Patients requiring planned pancreatoduodenectomy (robotic or open).
- Signed informed consent to participate in the study.
Exclusion
- Patients who refuse the procedure.
- Uncertainty about vascular involvement that could affect resectability.
- Poor general health status (American Society of Anesthesiologists \[ASA\] classification IV).
- Pancreatitis
Key Trial Info
Start Date :
September 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2027
Estimated Enrollment :
93 Patients enrolled
Trial Details
Trial ID
NCT06981273
Start Date
September 1 2025
End Date
September 1 2027
Last Update
May 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital del Mar
Barcelona, Spain